Home \ Library - Page 12

Library - Page 12

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

Improving the effectiveness of treatment of hypertensive encephalopathy with the drug Mexidol

Authors:
E.V. BOLOTOVA1, T.Yu. LUSHPAY2, I.V. KOVRIGINA2

1Federal State Budgetary Educational Institution of Higher Education “Kuban State Medical University” of the Ministry of Health of the Russian Federation, Krasnodar, Russia;
2State Budgetary Healthcare Institution “Research Institute — Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky” of the Ministry of Health of Krasnodar Krai, Krasnodar, Russia

Read more

The effect of submaximal doses of Mexidol on oxidative stress and inflammation processes in the acute period of ischemic stroke

Authors:
A.R. GODUNOVA, A.A. Rakhimova, O.I. LEONTIEV, I.G. TALIPOVA, R.M. YAKHIN, Sh.G. MUSIN

State Budgetary Healthcare Institution of the Republic of Tatarstan “Emergency Hospital”, Naberezhnye Chelny, Russia

Read more

Treatment of dizziness in elderly patients with chronic cerebrovascular pathology

Author:
S.N. DUMA

Research Institute of Therapy and Preventive Medicine-a branch of the Federal State University "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russia

Read more

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in acute and early restorations. Periods

Authors:
L.V. STAKHOVSKAYA1, N.A. SHAMALOV1, D.R. KHASANOVA2, E.V. MELNIKOVA3, A.S. AGAFINA4, K.V. GOLIKOV5, E.I. BOGDANOV6, A.A. YAKUPOVA6, L.V. ROSHKOVSKA7, L.V. LUKINYKH8, T.M. LOKSHTANOVA9, I.E. Poverennova10, L.A. SCHEPANKEVICH11

1Research Institute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Moscow, Russia;
2Interregional Clinical and Diagnostic Center, Kazan, Russia;
3St. Petersburg City Hospital No. 26, St. Petersburg, Russia;
4St. Petersburg City Hospital No. 40 of the Kurortny Administrative District, St. Petersburg, Russia;
5St. Petersburg City Multidisciplinary Hospital No. 2, St. Petersburg, Russia;
6Kazan State Medical University, Kazan, Russia;
7St. Petersburg Nikolaevskaya Hospital, St. Petersburg, Russia;
8Vsevolozhsk Clinical Interdistrict Hospital, Leningrad Region, Russia.
9MUBZ City Clinical Hospital No. 1 named after N.I. Pirogov, Samara, Russia;
10State Budgetary Healthcare Institution Samara Regional Clinical Hospital named after V.D. Seredavin, Samara, Russia;
11Federal State Budgetary Scientific Institution Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.

Read more

Modern protection strategies for hypoxic-itchemic brain damage

Authors:

Yanishevsky S.N.*, Tsygan N.V., Golokhvastov S.Yu. , Andreev R.V., Litvinenko I.V. , Karpova O.S., Yakovleva V.A.

*FSBVOU in "Military Medical Academy named after CM. Kirov ”, St. Petersburg, Russia

Place of publication:

Journal of Neurology and Psychiatry, 12, 2017

Read more

Features of anxiety manifestation in older patients with different types of mild cognitive impairment

Author:

Sidenkova A.P.

Federal State Budgetary Educational Institution of Higher Education "Ural State Medical University" of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia

Place of publication:

JOURNAL OF NEUROLOGY AND PSYCHIATRY, 11, 2017

Read more

Dodemic cognitive disorder. Directions of therapy

Author:

Sokolova L.P.

Place of publication:

Neuronyus, issue No. 11 (37) 2017

 

Read more

Modern approaches to neuroprotective therapy of ischemic stroke

Authors:

STAKHOVSKAYA L.V.*1, TYUTYUMOVA E.A.2*, FEDIN A.I.*2

1*Research Institute of Cerebrovascular Pathology and Stroke,
N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia;

2*Federal State Budgetary Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation, Moscow, Russia

Place of publication:

JOURNAL OF NEUROLOGY AND PSYCHIATRY, 8, 2017

 

Read more

Morphofunctional bases of the development of vascular cognitive and emotional disorders

Author:

Zhitkova Yu.V.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2017

Read more

Modern criteria for rational diagnosis and treatment of cerebrovascular diseases

Authors:

BUTAKOVA Y.S., ZHIVOLUPOV S.A., SAMARTSEV I.N.

Place of publication:

Neuronyus, issue No. 10 (36) October 2017

Read more

Modern paradigm of rational therapy of strokes

Zhivolupov S.A., Butakova Yu.S., Samartsev I.N.

Department of Nervous Diseases of the Military Medical Academy; Primary vascular branch of the Novodvinsk City Hospital, St. Petersburg, Russia

Place of publication:

Journal of Neurology and Psychiatry, 8, 2016

Read more

Mexidol's effectiveness with carotid endarterctomy in patients with stenosis cerebral atherosclerosis

Authors:

GOLOVKIN V.I., POPOVA L.O., Svetlikov A.V., SHAPOVALOV A.S.

Place of publication:

Journal of Neurology and Psychiatry, 1, 2016

Read more

Chronic cerebrovascular failure: description of the clinical case

Authors:

VAKHNINA N.V., GROMOVA D.O., ZAKHAROV V.V., TARAPOVSKAYA A.V.

Place of publication:

Therapeutic archive 4, 2016

Read more

The systemic stressful effect of Mexidol in chronic brain ischemia

Authors:

Antipenko E.A.1*, Deryugina A.V. 2*, Gustov A.V.1*

1*GBOU VPO Nizhny Novgorod State Medical Academy of the Ministry of Health of Russia, Nizhny Novgorod;

2*National Research University "Nizhny Novgorod State University named after N.I. Lobachevsky ”, Nizhny Novgorod

Place of publication:

Journal of Neurology and Psychiatry, 4, 2016

Read more

Optimization of lipidsiting therapy in patients with ischemic stroke and type 2 diabetes mellitus

Author:
L.A. SHCHEPANKEVICH, Yu.A. NIKOLAEV, N.A. DOLGOVA

FGBNU "Research Institute of Experimental and Clinical Medicine", Novosibirsk

Read more

The effectiveness of combined therapy with Mexidol and cerebrolysine of chronic brain ischemia

Authors:
S.V. BEREZHNAYA1, E.Z. YAKUPOV2, Yu.A. ZAKHAROV3

1State Autonomous Healthcare Institution "City Polyclinic No. 6", Kazan;
2State Budgetary Educational Institution of Higher Professional Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation, Kazan;
3State Budgetary Educational Institution of Higher Professional Education "Institute of Physics of Kazan (Volga Region) Federal University", Kazan, Russia

Read more
1 … 10 11 12 13 14

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com